Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this systematic review, the authors reported that both FUE and FUT hair transplant techniques induce oxidative stress and inflammation, impacting graft survival, but interventions like PRGF, CO2 laser, and dermal microtissues can enhance healing, reduce inflammation, and improve follicular survival.

This source provides a comprehensive reference on recent advancements and innovative approaches in the diagnosis and treatment of common dermatological conditions, highlighting significant updates for clinical practice in dermatology.

In this study, researchers investigated the use of the Pulse Booster Drug Delivery Mesojectgun technology for non-invasive treatment of scalp conditions, finding improvements in hair volume, thickness, and reduction of hair loss in four participants with alopecia after applying specific active ingredients.

In this case report, a 22-year-old experiencing alopecia androgénica developed low blood pressure and elevated heart rate after using an oral minoxidil and dutasteride combination, highlighting the need for careful monitoring and personalized therapy in managing medication side effects.

This article discusses the organizational aspects of the II National Academic Congress of Dermatology in Brazil and reports no new research findings.

This article reviews the management of lower urinary tract symptoms, highlighting drug therapy advancements that have reduced the frequency of surgical interventions.

In this descriptive retrospective study, researchers reported that low-dose oral minoxidil (0.25-5mg/day) for androgenic alopecia demonstrated a good safety profile, with 84.4% of 641 patients experiencing no adverse effects and only 1.4% discontinuing due to side effects that resolved with dose reduction or withdrawal.

This study found that severe obesity is positively associated with more severe lower urinary tract symptoms compared to moderate obesity in patients with prostatic enlargement.

This dissertation found that finasteride reduced prostate volume by 6.3% and total serum PSA by 10.51% in young patients over one year.

This case report describes a 59-year-old woman diagnosed with frontal fibrosing alopecia, presenting with scarring alopecia and perifollicular erythematous papules.

This review suggests that finasteride at 1 mg/day reduces PSA levels similarly to 5 mg/day, but differences in prostate dihydrotestosterone levels may affect prostate cancer diagnosis and prevention.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

Finasteride lowers prostate cancer risk but may increase high-grade tumors and sexual side effects.

A rare pancreatic tumor caused a woman's male-like features, treated successfully with surgery and medication.

This review presents possible classifications of psychological disorders that significantly impact dermatology, along with their clinical characteristics and comorbidities, highlighting lesions as potential warning signs based on DSM-5 and ICD-10 codes.

In this review, researchers examined current knowledge on alopecia areata, finding it affects approximately 2% of individuals, with a likely autoimmune and genetic basis, and highlighting its association with other medical and psychiatric conditions, although no cure currently exists.

Cosmetic surgery should be personalized for different ethnic groups to ensure the best results and patient satisfaction.

Female pattern hair loss, common in women, can be treated with various methods like minoxidil, anti-androgen treatments, and light therapy, but early intervention and realistic expectations are crucial.

This study found that men with early-onset androgenetic alopecia had larger prostate volumes and lower urinary flow rates compared to those without the condition, suggesting a potential link between AGA and urinary symptoms.

This review discusses the epidemiology and available treatments for male androgenetic alopecia, noting that while current therapies can slow progression, they provide only partial hair restoration, and further research is needed for new strategies.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

This article discusses the clinical presentation, histopathologic findings, and pathogenesis hypotheses of vitiligo without reporting new clinical results.

This review discusses the roles of key developmental signaling pathways in mammalian skin repair compared to skin development, and suggests these insights could lead to better wound healing therapies, but it reports no new findings.

This paper discusses the role of steroid sulfatase in hormone-dependent tumors and highlights the development of potent inhibitors, noting the commencement of a phase I trial for one inhibitor in postmenopausal breast cancer patients.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

This document extends previous recommendations by the National Lipid Association for managing dyslipidemia, focusing on lifestyle therapies, special patient groups, and strategies to enhance adherence and patient outcomes.